Safety of Switching to Migalastat From Enzyme Replacement Therapy in Fabry Disease: Experience From the Phase 3 ATTRACT Study
American Journal of Medical Genetics, Part A - United States
doi 10.1002/ajmg.a.61105
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 28, 2019
Authors
Publisher
Wiley